2% lidocaine hci

Generic: 2% lidocaine hci

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name 2% lidocaine hci
Generic Name 2% lidocaine hci
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INFILTRATION PERINEURAL
Active Ingredients

lidocaine hydrochloride 20 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1326
Product ID 51662-1326_100cb889-1a79-6252-e063-6394a90a9221
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA088327
Listing Expiration 2026-12-31
Marketing Start 2018-10-22

Pharmacologic Class

Classes
amide local anesthetic [epc] amides [cs] antiarrhythmic [epc] local anesthesia [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621326
Hyphenated Format 51662-1326

Supplemental Identifiers

RxCUI
1010671
UNII
V13007Z41A

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name 2% lidocaine hci (source: ndc)
Generic Name 2% lidocaine hci (source: ndc)
Application Number ANDA088327 (source: ndc)
Routes
INFILTRATION PERINEURAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 50 mL in 1 VIAL, MULTI-DOSE (51662-1326-1)
  • 25 POUCH in 1 CASE (51662-1326-3) / 1 mL in 1 POUCH (51662-1326-2)
source: ndc

Packages (2)

51662-1326-1 50 mL in 1 VIAL, MULTI-DOSE (51662-1326-1) 51662-1326-3 25 POUCH in 1 CASE (51662-1326-3) / 1 mL in 1 POUCH (51662-1326-2)

Ingredients (1)

lidocaine hydrochloride (20 mg/mL)

Linked Drug Pages (1)

2% LIDOCAINE HCI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INFILTRATION", "PERINEURAL"], "spl_id": "100cb889-1a79-6252-e063-6394a90a9221", "openfda": {"unii": ["V13007Z41A"], "rxcui": ["1010671"], "spl_set_id": ["78d8fb0a-bfae-6599-e053-2991aa0a2e03"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL, MULTI-DOSE (51662-1326-1)", "package_ndc": "51662-1326-1", "marketing_start_date": "20181022"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1326-3)  / 1 mL in 1 POUCH (51662-1326-2)", "package_ndc": "51662-1326-3", "marketing_start_date": "20200615"}], "brand_name": "2% LIDOCAINE HCI", "product_id": "51662-1326_100cb889-1a79-6252-e063-6394a90a9221", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Local Anesthesia [PE]"], "product_ndc": "51662-1326", "generic_name": "2% LIDOCAINE HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "2% LIDOCAINE HCI", "active_ingredients": [{"name": "LIDOCAINE HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA088327", "marketing_category": "ANDA", "marketing_start_date": "20181022", "listing_expiration_date": "20261231"}